Bios Capital Management, LP Lantern Pharma Inc. Transaction History
Bios Capital Management, LP
- $79.2 Billion
- Q1 2025
A detailed history of Bios Capital Management, LP transactions in Lantern Pharma Inc. stock. As of the latest transaction made, Bios Capital Management, LP holds 1,207,709 shares of LTRN stock, worth $4.32 Million. This represents 5.4% of its overall portfolio holdings.
Number of Shares
1,207,709
Previous 1,207,709
-0.0%
Holding current value
$4.32 Million
Previous $3.85 Billion
10.97%
% of portfolio
5.4%
Previous 4.09%
Shares
1 transactions
Others Institutions Holding LTRN
# of Institutions
35Shares Held
2.41MCall Options Held
17.1KPut Options Held
1.3K-
Vanguard Group Inc Valley Forge, PA364KShares$1.3 Million0.0% of portfolio
-
Cm Management, LLC200KShares$716,0000.77% of portfolio
-
Geode Capital Management, LLC Boston, MA90.5KShares$324,0040.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny88.8KShares$317,9040.0% of portfolio
-
New Edge Advisors, LLC New Orleans, LA59.9KShares$214,5270.0% of portfolio
About Lantern Pharma Inc.
- Ticker LTRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,830,900
- Market Cap $38.8M
- Description
- Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...